Company · CIK 0001771917
Karuna Therapeutics, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- 8-KCurrent report0001140361-24-013728 · 325.7 KBSEC(opens sec.gov)
- 10-K/AKaruna Therapeutics, Inc.0000950170-24-031505 · 6.5 MBSEC(opens sec.gov)
- 8-KCurrent report0001140361-24-013155 · 168.8 KBSEC(opens sec.gov)
- 8-KCurrent report0001140361-24-012807 · 177.6 KBSEC(opens sec.gov)
- 8-KCurrent report0001140361-24-010584 · 343.6 KBSEC(opens sec.gov)
- 10-KAnnual report0000950170-24-018395 · 16.0 MBSEC(opens sec.gov)
- 8-KCurrent report0000950170-24-018393 · 300.1 KBSEC(opens sec.gov)
- SC 13GKaruna Therapeutics, Inc.0001897612-24-001265 · 6.5 KBSEC(opens sec.gov)
- SC 13G/AKaruna Therapeutics, Inc.0000080255-24-000743 · 6.5 KBSEC(opens sec.gov)
- SC 13G/AKaruna Therapeutics, Inc.0001104659-24-021271 · 13.0 KBSEC(opens sec.gov)
Insiders
- Alexandria Venture Investments, LLC10% Owner
- ARCH Venture Fund IX, L.P.10% Owner
- ARCH Venture Partners IX, LLC10% Owner
- ARCH Venture Partners IX, L.P.10% Owner
- Brannan Stephen K.Chief Medical Officer
- Brown Jason ParkerChief Financial Officer
- BYBEE CLINTON10% Owner
- CHOWRIRA BHARAT MDirector
- COUGHLIN CHRISTOPHER JDirector
- CRANDELL KEITH10% Owner
Tickers
No tickers on record.
Addresses
business
99 HIGH STREET 26TH FLOOR
BOSTON, MA, 02110
mailing
99 HIGH STREET 26TH FLOOR
BOSTON, MA, 02110
Same industry